News

AbstractIntroduction: Cardiac amyloidosis, primarily comprising transthyretin amyloid cardiomyopathy (ATTR-CM) and light-chain amyloidosis with cardiac involvement…

AbstractGastrointestinal amyloidosis is a rare but often a manifestation of an advanced form of systemic amyloidosis that carries a poor prognosis. Its presentation…

Every day, your heart works tirelessly, pumping blood that delivers the oxygen and nutrients your body needs to function. February is American Heart Month, a…

In this video, Sean Riley from New Hampshire shares his health journey with amyloidosis, a rare genetic condition caused by mutations in certain genes that lead to…

AbstractBackground and aim of the studyWild-type transthyretin cardiac amyloidosis (ATTRwt-CA) is an increasingly recognized disease in elderly individuals. We…

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.If you or a loved one has been diagnosed with…

Data availabilityThe datasets generated and analysed during the current study are available from the corresponding author on reasonable request.FundingOpen access…

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.If you have been diagnosed with transthyretin amyloid…

The rare disease community needs More Access Than You Can Imagine! This Rare Disease Day, the NORD Rare Disease Centers of Excellence (RD CoE) Program will…

The Rare Disease Symposium 2026 is hosted by the UCSF Catalyst Program and Institute for Human Genetics, in partnership with Foundation Ipsen. Rare diseases affect…